1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: Update from the phase I/II TRIDENT-1 trial.
Saved in:
| Title: | 1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: Update from the phase I/II TRIDENT-1 trial. |
|---|---|
| Authors: | Solomon, B.J.1 (AUTHOR), Drilon, A.2 (AUTHOR), Lin, J.J.3 (AUTHOR), Bazhenova, L.4 (AUTHOR), Goto, K.5 (AUTHOR), De Langen, J.6 (AUTHOR), Kim, D-W.7 (AUTHOR), Wolf, J.8 (AUTHOR), Springfeld, C.9 (AUTHOR), Popat, S.10 (AUTHOR), Lim, D.W-T.11 (AUTHOR), Baik, C.S.12 (AUTHOR), Hervieu, A.13 (AUTHOR), Moreno Garcia, V.14 (AUTHOR), Yang, N.15 (AUTHOR), Thamake, S.16 (AUTHOR), Ades, F.17 (AUTHOR), Trone, D.18 (AUTHOR), Besse, B.19 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS787-S788. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173099149 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: Update from the phase I/II TRIDENT-1 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Solomon%2C+B%2EJ%2E%22">Solomon, B.J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Drilon%2C+A%2E%22">Drilon, A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+J%2EJ%2E%22">Lin, J.J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bazhenova%2C+L%2E%22">Bazhenova, L.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goto%2C+K%2E%22">Goto, K.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Langen%2C+J%2E%22">De Langen, J.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kim%2C+D-W%2E%22">Kim, D-W.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wolf%2C+J%2E%22">Wolf, J.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Springfeld%2C+C%2E%22">Springfeld, C.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Popat%2C+S%2E%22">Popat, S.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lim%2C+D%2EW-T%2E%22">Lim, D.W-T.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baik%2C+C%2ES%2E%22">Baik, C.S.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hervieu%2C+A%2E%22">Hervieu, A.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moreno+Garcia%2C+V%2E%22">Moreno Garcia, V.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+N%2E%22">Yang, N.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thamake%2C+S%2E%22">Thamake, S.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ades%2C+F%2E%22">Ades, F.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Trone%2C+D%2E%22">Trone, D.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Besse%2C+B%2E%22">Besse, B.</searchLink><relatesTo>19</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS787-S788. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173099149 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.09.2405 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S787 Titles: – TitleFull: 1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: Update from the phase I/II TRIDENT-1 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Solomon, B.J. – PersonEntity: Name: NameFull: Drilon, A. – PersonEntity: Name: NameFull: Lin, J.J. – PersonEntity: Name: NameFull: Bazhenova, L. – PersonEntity: Name: NameFull: Goto, K. – PersonEntity: Name: NameFull: De Langen, J. – PersonEntity: Name: NameFull: Kim, D-W. – PersonEntity: Name: NameFull: Wolf, J. – PersonEntity: Name: NameFull: Springfeld, C. – PersonEntity: Name: NameFull: Popat, S. – PersonEntity: Name: NameFull: Lim, D.W-T. – PersonEntity: Name: NameFull: Baik, C.S. – PersonEntity: Name: NameFull: Hervieu, A. – PersonEntity: Name: NameFull: Moreno Garcia, V. – PersonEntity: Name: NameFull: Yang, N. – PersonEntity: Name: NameFull: Thamake, S. – PersonEntity: Name: NameFull: Ades, F. – PersonEntity: Name: NameFull: Trone, D. – PersonEntity: Name: NameFull: Besse, B. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2023 Supplement 2 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
